Northrop Grumman's B-21 Overruns May Finally Surface in Tomorrow's Report, or Later

Northrop Grumman Corporation reports first-quarter 2026 earnings tomorrow before market open, with Wall Street expecting EPS of $6.08 on revenue estimates around $9.85 billion. The defense giant enters this release riding momentum from three consecutive quarterly beats and a record $95.7 billion backlog, but faces questions about whether its Sentinel ICBM program acceleration and space logistics wins can sustain the growth trajectory that drove shares up 14% over the past year. With the options market pricing a 5.88% post-earnings move and analyst sentiment improving to a 4.09 average rating, investors will scrutinize whether Northrop can deliver on its full-year guidance of $28.11 EPS while navigating geopolitical tailwinds and valuation concerns.

Part 1: Earnings Preview

Northrop Grumman Corporation is a leading U.S. aerospace and defense contractor specializing in autonomous systems, space technology, missile defense, and advanced aircraft platforms including the B-21 Raider stealth bomber and F-35 components. The company operates through four segments—Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems—serving government and commercial customers with integrated command, control, communications, and intelligence solutions.

Northrop reports Q1 2026 results tomorrow morning, April 21, with analysts expecting EPS of $6.08 and revenue of approximately $9.85 billion. The company most recently reported Q4 2025 EPS of $7.23, beating estimates by 3.29% on revenue of $11.71 billion. Compared to Q1 2025's actual EPS of $6.06, the current consensus implies modest year-over-year growth of 0.33%, reflecting a more normalized quarter following the strong Q4 performance.

Sentinel ICBM Program Momentum: The acceleration of Northrop's Ground-Based Strategic Deterrent (Sentinel) program represents a critical narrative heading into earnings. Recent updates confirm the program is advancing toward a 2027 first flight and early-2030s initial capability, with testing, infrastructure prototyping, and supply-chain readiness all progressing on schedule. This multi-decade contract provides exceptional revenue visibility and validates Northrop's execution capabilities on complex nuclear modernization programs, potentially offsetting concerns about near-term growth deceleration.

Space Operations and Recurring Revenue: Northrop's successful Cygnus XL cargo mission to the International Space Station demonstrates the company's ability to generate steady, recurring revenue from space logistics contracts with NASA and commercial partners. This diversification beyond traditional defense platforms helps stabilize cash flows and positions the company to capture growth in the expanding space economy, particularly as geopolitical tensions drive increased satellite and space-based defense spending.

Valuation and Growth Expectations: Despite strong operational performance, some analysts caution that Northrop's valuation may limit upside if growth expectations slip. With shares trading near recent highs and the consensus EPS estimate implying only modest sequential improvement from Q4's $7.23, investors will scrutinize whether the company can sustain double-digit margins across segments and deliver on its full-year guidance range of $27.77–$28.68. The debate centers on whether current multiples adequately reflect the long-term revenue runway from programs like Sentinel or whether near-term execution risks warrant a more cautious stance.

Analyst commentary ahead of the release highlights Northrop's favorable setup for another earnings surprise, backed by a strong beat history and solid execution across all four business segments. Coverage from multiple firms notes the company's ability to consistently exceed expectations, with recent price target increases reflecting confidence in the multi-year defense spending cycle and Northrop's positioning within precision navigation, radar systems, and next-generation aircraft programs.

Part 2: Historical Earnings Performance

Northrop Grumman has established a strong pattern of exceeding analyst expectations, beating estimates in three of the past four quarters with an average surprise of 6.76% when excluding the Q1 2025 miss. The company's most recent quarter (Q4 2025) delivered EPS of $7.23 versus estimates of $7.00, a 3.29% beat, while Q3 2025 produced an impressive 18.18% surprise with $7.67 against a $6.49 consensus. Q2 2025 similarly outperformed with $7.11 versus $6.71 expected, a 5.96% beat.

The lone miss came in Q1 2025, when Northrop reported $6.06 against a $6.21 estimate, a -2.42% shortfall. However, the subsequent three quarters demonstrated accelerating momentum, with surprise percentages expanding from 5.96% to 18.18% before moderating to 3.29% in Q4. This pattern suggests the company has successfully navigated operational challenges and consistently delivered above Street expectations, building credibility with investors.

The trend of sequential EPS growth from Q1 through Q3 2025 ($6.06 → $7.11 → $7.67) followed by a modest pullback to $7.23 in Q4 reflects typical defense industry seasonality and program timing. With Q1 2026 estimates of $6.08 representing only a 0.33% year-over-year increase from Q1 2025's $6.06, the bar appears set relatively low, potentially positioning Northrop for another positive surprise if operational execution remains strong.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Northrop Grumman typically reports earnings before market open, meaning Day 0 represents the first full trading session where investors react to results, while Day +1 captures follow-through momentum.

Historical price behavior reveals significant volatility around Northrop's earnings releases, with an average absolute Day 0 move of 4.53% and intraday range of 5.22%. The most dramatic reaction occurred on April 22, 2025, when shares plunged 12.66% following the Q1 2025 miss, demonstrating the market's sensitivity to execution shortfalls. Conversely, the July 22, 2025 release triggered a 9.41% surge after the company's 5.96% earnings beat, showing how positive surprises can drive substantial upside.

More recent quarters have exhibited more moderate reactions, with the January 27, 2026 release producing a 2.69% Day 0 gain and the October 21, 2025 report generating only a -0.44% move despite solid results. Day +1 follow-through averages 1.24%, suggesting initial reactions tend to persist rather than reverse, though the magnitude diminishes significantly after the first session. The 5.22% average intraday range on Day 0 indicates substantial intraday volatility regardless of directional bias, creating both risk and opportunity for traders positioning around the release.

Part 2.2: Options Market Expected Move

The options market is pricing a 5.88% expected move for the May 15, 2026 expiration, slightly above the 4.53% average historical Day 0 move but well within the range of recent volatility. This implies options traders are anticipating a moderately elevated reaction compared to the typical post-earnings move, potentially reflecting uncertainty around full-year guidance confirmation and Sentinel program updates.

Part 3: What Analysts Are Saying

Analyst sentiment on Northrop Grumman stands firmly bullish, with an average rating of 4.09 on the five-point scale and a mean price target of $753.00, implying 14.6% upside from the current $656.98 price. The consensus has improved over the past month, with strong buy ratings increasing from 11 to 12 while the overall recommendation score ticked up from 4.05 to 4.09.

The rating distribution shows 12 strong buys, 1 moderate buy, and 10 holds, with zero sell ratings across the 23 analysts covering the stock. This 57% strong buy concentration reflects confidence in Northrop's execution capabilities and long-term growth trajectory, particularly given the record backlog and multi-year defense spending cycle. The absence of any bearish ratings is notable, suggesting even cautious analysts view the risk/reward as neutral rather than negative.

Price targets span a wide range from $604.00 to $849.00, with the $753.00 mean representing a balanced view between bulls anticipating continued margin expansion and bears concerned about valuation. The $849.00 high target implies 29.2% upside and likely reflects optimistic assumptions about Sentinel program acceleration and sustained double-digit segment margins, while the $604.00 low target sits 8.1% below current levels, suggesting limited downside risk even in a bearish scenario. The improving sentiment trend and rising strong buy count indicate analysts are gaining confidence as Northrop demonstrates consistent operational execution and program wins.

Part 4: Technical Picture

Northrop Grumman's technical setup heading into earnings shows deteriorating momentum, with the Barchart Technical Opinion weakening from 80% Buy a month ago to 40% Buy last week and currently standing at just 24% Buy. This sharp decline in bullish conviction reflects the stock's recent underperformance, as shares have pulled back from recent highs and now trade below most key moving averages.

Timeframe Analysis:

• Short-term (Hold): Neutral signal indicates near-term momentum has stalled, with the stock consolidating after its recent decline
• Medium-term (50% Buy): Moderate buy signal suggests the intermediate trend remains constructive despite short-term weakness
• Long-term (50% Buy): Moderate buy signal reflects the stock's longer-term uptrend remains intact above the 200-day moving average

Trend Characteristics: The Soft strength combined with a Weakening direction suggests the technical environment is fragile heading into earnings, with momentum fading and support levels being tested.

The stock currently trades at $656.98, positioned below the 5-day ($670.75), 10-day ($677.73), 20-day ($682.54), 50-day ($707.33), and 100-day ($657.43) moving averages, but remains above the critical 200-day moving average at $617.39. This configuration indicates short-term technical damage, with the stock having broken below multiple support levels during its recent pullback from the $707+ area. The 100-day moving average at $657.43 represents immediate resistance just above current levels, while the 200-day at $617.39 provides crucial long-term support approximately 6% below the current price.

The overall technical setup presents a cautionary picture for earnings, with deteriorating momentum indicators and the stock trading in a vulnerable position below most moving averages. However, the fact that shares remain above the 200-day moving average and retain moderate buy signals in the medium and long-term timeframes suggests the broader uptrend has not been broken. A strong earnings beat could catalyze a recovery back toward the 50-day moving average near $707, while a disappointment risks testing the 200-day support at $617. The 5.88% options-implied move aligns with the stock's historical volatility, suggesting traders should prepare for significant price action in either direction.